Insulin Resistance and Metabolic Syndrome

Insulin resistance lies at the core of metabolic syndrome, a cluster of metabolic abnormalities including central obesity, dyslipidemia, hypertension, and impaired glucose metabolism. Insulin resistance disrupts cellular signaling pathways, leading to metabolic dysregulation and increased cardiovascular risk. Mechanisms linking insulin resistance to metabolic syndrome involve adipose tissue dysfunction, chronic low-grade inflammation, and mitochondrial dysfunction. Lifestyle interventions targeting insulin sensitivity through dietary modifications and exercise can mitigate metabolic syndrome components and reduce cardiovascular risk. Pharmacotherapeutic approaches also aim to improve insulin sensitivity and address individual components of metabolic syndrome, emphasizing personalized management strategies in high-risk individuals.

    Related Conference of Insulin Resistance and Metabolic Syndrome

    November 13-14, 2024

    33rd International Diabetes and Healthcare Conference

    Paris, France
    November 18-19, 2024

    7th Annual Meeting on Diabetes and Endocrinology

    Paris, France
    November 18-19, 2024

    3rd International Summit on Hormonal Disorders

    Madrid, Spain
    November 22-23, 2024

    20th World Congress on Endocrinology & Diabetes

    Amsterdam, Netherlands
    November 27-28, 2024

    14th World Congress on Endocrinology and Diabetes

    Paris, France
    February 24-25, 2025

    34th European Diabetes Congress

    London, UK
    March 17-18, 2025

    5th European Endocrinology and Diabetes Congress

    Paris, France
    April 10-11, 2025

    5th World Congress on Endocrine and Diabetes

    Dubai, UAE
    May 19-20, 2025

    6th World Summit on Diabetes

    Rome, Italy
    June 04-05, 2025

    4th World Congress on Diabetes and Pediatric Endocrinology

    Edinburgh, Scotland

    Insulin Resistance and Metabolic Syndrome Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in